Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer
Simple Summary
- Supplementary File 1:
PDF-Document (PDF, 4727 KiB)
Araujo, A.; Cook, L.M.; Frieling, J.S.; Tan, W.; Copland, J.A., II; Kohli, M.; Gupta, S.; Dhillon, J.; Pow-Sang, J.; Lynch, C.C.; Basanta, D. Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer. Cancers 2021, 13, 677. https://doi.org/10.3390/cancers13040677
Araujo A, Cook LM, Frieling JS, Tan W, Copland JA II, Kohli M, Gupta S, Dhillon J, Pow-Sang J, Lynch CC, Basanta D. Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer. Cancers. 2021; 13(4):677. https://doi.org/10.3390/cancers13040677
Chicago/Turabian StyleAraujo, Arturo, Leah M. Cook, Jeremy S. Frieling, Winston Tan, John A. Copland II, Manish Kohli, Shilpa Gupta, Jasreman Dhillon, Julio Pow-Sang, Conor C. Lynch, and David Basanta. 2021. "Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer" Cancers 13, no. 4: 677. https://doi.org/10.3390/cancers13040677